It has been reported that transthyretin, a secreted protein downstream of STAT3, could promote oncogenic gene activation, enhance cytokine function in the tumor microenvironment as well as increase the production of reactive oxygen species to facilitate the progression of lung cancer (34). This evidence concerns the gene STAT3 and lung carcinoma.